INMED PHARMACEUTICALS INC

$INM
← All companies Sign in to track
Institutional coverage

2 13F filers hold $INM.

13F holders
2
Insider buys · 90d
13code P
Congress · 90d
0

Smart Money · top-200 alpha cohort

No exposure this quarter

No top-200 alpha managers currently hold $INM. The institutional holders table below shows the broader 13F picture.

Institutional holders

Top 2 of 2 · Source: 13F-HR
01
ADAR1 Capital Management, LLC
0.06% of portfolio
800,000 sh
02
Citadel
—
26,084 sh

Insider activity · last 90 days

48 transactions · 12 filers
17 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
16 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
16 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
16 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
16 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
16 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
16 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
02 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
02 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
02 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
02 Jul 2026
Unknown —
▲ BOUGHT
—
—
P
02 Jul 2026
Unknown —
▲ BOUGHT
—
—
P

Transaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $INM in the recent window.

Convergence · $INM

Pattern cards reflect public SEC EDGAR and Congressional filing data only. Detection uses filing dates; trade execution dates may differ. Past convergence patterns do not predict future returns. Nothing here is investment advice.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 16:46 UTC.